Literature DB >> 11891877

Systemic administration of 1R,4S-4-amino-cyclopent-2-ene-carboxylic acid, a reversible inhibitor of GABA transaminase, blocks expression of conditioned place preference to cocaine and nicotine in rats.

Charles R Ashby1, Mousumi Paul, Eliot L Gardner, Madina R Gerasimov, Stephen L Dewey, Ian C Lennon, Stephen J C Taylor.   

Abstract

We examined the effect of 1R,4S-4-amino-cyclopent-2-ene-carboxylic acid (ACC), a reversible inhibitor of GABA transaminase, on the expression of conditioned place preference response to cocaine and nicotine in rats. Cocaine (20 mg/kg i.p.) and nicotine (0.4 mg/kg s.c.), but not vehicle or 300 mg/kg i.p. of ACC, produced a significant conditioned place preference response. Pretreatment of animals with 300 and 75 mg/kg i.p. of ACC significantly attenuated the expression of the cocaine- and nicotine-induced conditioned place preference responses, respectively. These results are the first to suggest that reversible inhibition of GABA transaminase may be useful in blocking cue-induced relapse to nicotine and cocaine. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891877     DOI: 10.1002/syn.10052

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  12 in total

1.  (1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a potent γ-aminobutyric acid aminotransferase inactivator for the treatment of cocaine addiction.

Authors:  Yue Pan; Madina R Gerasimov; Trine Kvist; Petrine Wellendorph; Karsten K Madsen; Elena Pera; Hyunbeom Lee; Arne Schousboe; Mary Chebib; Hans Bräuner-Osborne; Cheryl M Craft; Jonathan D Brodie; Wynne K Schiffer; Stephen L Dewey; Steven R Miller; Richard B Silverman
Journal:  J Med Chem       Date:  2011-12-30       Impact factor: 7.446

2.  The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions.

Authors:  Arlene C Pak; Charles R Ashby; Christian A Heidbreder; Maria Pilla; Jeremy Gilbert; Zheng-Xiong Xi; Eliot L Gardner
Journal:  Int J Neuropsychopharmacol       Date:  2006-08-31       Impact factor: 5.176

3.  Genetic analysis of the psychostimulant effects of nicotine in chromosome substitution strains and F2 crosses derived from A/J and C57BL/6J progenitors.

Authors:  Alan E Boyle; Kathryn J Gill
Journal:  Mamm Genome       Date:  2008-12-13       Impact factor: 2.957

4.  A risk allele for nicotine dependence in CHRNA5 is a protective allele for cocaine dependence.

Authors:  Richard A Grucza; Jen C Wang; Jerry A Stitzel; Anthony L Hinrichs; Scott F Saccone; Nancy L Saccone; Kathleen K Bucholz; C Robert Cloninger; Rosalind J Neuman; John P Budde; Louis Fox; Sarah Bertelsen; John Kramer; Victor Hesselbrock; Jay Tischfield; John I Nurnberger; Laura Almasy; Bernice Porjesz; Samuel Kuperman; Marc A Schuckit; Howard J Edenberg; John P Rice; Alison M Goate; Laura J Bierut
Journal:  Biol Psychiatry       Date:  2008-06-02       Impact factor: 13.382

5.  Nicotine induces conditioned place preferences over a large range of doses in rats.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2004-11-18       Impact factor: 4.530

6.  Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats.

Authors:  Bernard Le Foll; Carrie E Wertheim; Steven R Goldberg
Journal:  Neurosci Lett       Date:  2008-08-05       Impact factor: 3.046

7.  Intravenous nicotine conditions a place preference in rats using an unbiased design.

Authors:  Jamie L Wilkinson; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2007-09-01       Impact factor: 3.533

Review 8.  A neuropeptide-centric view of psychostimulant addiction.

Authors:  B Boutrel
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

Review 9.  The "stop" and "go" of nicotine dependence: role of GABA and glutamate.

Authors:  Manoranjan S D'Souza; Athina Markou
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

Review 10.  Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation.

Authors:  Xia Li; Svetlana Semenova; Manoranjan S D'Souza; Astrid K Stoker; Athina Markou
Journal:  Neuropharmacology       Date:  2013-06-07       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.